Header Logo

Connection

DANIEL MUSHER to Anti-Bacterial Agents

Back to Details
This is a "connection" page, showing publications DANIEL MUSHER has written about Anti-Bacterial Agents.
DANIEL MUSHER
Connection Strength
5.296
Anti-Bacterial Agents
  1. Amoxicillin vs. ceftriaxone to treat pneumonia caused by amoxicillin-non-susceptible Streptococcus pneumoniae. Antimicrob Agents Chemother. 2025 Sep 03; 69(9):e0078025.
    View in: PubMed
    Score: 0.413
  2. Give Penicillin or Ceftriaxone: Neurosyphilis Does Not Deal in Absolutes. Clin Infect Dis. 2024 05 15; 78(5):1386-1387.
    View in: PubMed
    Score: 0.379
  3. Clinical Diagnosis, Viral PCR, and Antibiotic Utilization in Community-Acquired Pneumonia. Am J Ther. 2016 May-Jun; 23(3):e766-72.
    View in: PubMed
    Score: 0.217
  4. The yield of sputum culture in bacteremic pneumococcal pneumonia after initiation of antibiotics. Clin Infect Dis. 2014 Jun; 58(12):1782-3.
    View in: PubMed
    Score: 0.187
  5. Rates of killing of methicillin-resistant Staphylococcus aureus by ceftaroline, daptomycin, and telavancin compared to that of vancomycin. Scand J Infect Dis. 2012 Aug; 44(8):620-2.
    View in: PubMed
    Score: 0.166
  6. Acute kidney injury associated with trimethoprim/sulfamethoxazole. J Antimicrob Chemother. 2012 May; 67(5):1271-7.
    View in: PubMed
    Score: 0.162
  7. Azithromycin for prevention of exacerbations of COPD. N Engl J Med. 2011 12 08; 365(23):2234; author reply 2236.
    View in: PubMed
    Score: 0.160
  8. Benefits and costs of rapid drug susceptibility in Staphylococcus aureus bacteremia. Clin Infect Dis. 2011 Apr 15; 52(8):1079; author reply 1079-80.
    View in: PubMed
    Score: 0.153
  9. New modalities in treating pneumococcal pneumonia. Hosp Pract (1995). 2011 Apr; 39(2):89-96.
    View in: PubMed
    Score: 0.153
  10. Impact of an antibiotic restriction program on antibiotic utilization in the treatment of community-acquired pneumonia in a Veterans Affairs Medical Center. Infection. 2011 Feb; 39(1):53-8.
    View in: PubMed
    Score: 0.151
  11. Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results. Infect Control Hosp Epidemiol. 2010 Oct; 31(10):1043-8.
    View in: PubMed
    Score: 0.147
  12. Dichotomy between content and interpretation. Clin Infect Dis. 2009 Oct 01; 49(7):1140.
    View in: PubMed
    Score: 0.137
  13. Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study. Clin Infect Dis. 2009 Feb 15; 48(4):e41-6.
    View in: PubMed
    Score: 0.132
  14. Clinical and microbiological end points in the treatment of pneumonia. Clin Infect Dis. 2008 Dec 01; 47 Suppl 3:S207-9.
    View in: PubMed
    Score: 0.130
  15. Outcomes of treatment for hematogenous Staphylococcus aureus vertebral osteomyelitis in the MRSA ERA. J Infect. 2008 Aug; 57(2):128-31.
    View in: PubMed
    Score: 0.126
  16. Treatment of clostridium difficile colitis in the critical care setting. Crit Care Clin. 2008 Apr; 24(2):279-91, viii.
    View in: PubMed
    Score: 0.124
  17. Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis. Am J Health Syst Pharm. 2007 Nov 15; 64(22):2359-63.
    View in: PubMed
    Score: 0.121
  18. Clostridium difficile: recent epidemiologic findings and advances in therapy. Pharmacotherapy. 2007 Jul; 27(7):1029-39.
    View in: PubMed
    Score: 0.118
  19. Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide. J Antimicrob Chemother. 2007 Apr; 59(4):705-10.
    View in: PubMed
    Score: 0.115
  20. Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 2006 Sep; 58(3):680-3.
    View in: PubMed
    Score: 0.110
  21. Nitazoxanide for the treatment of Clostridium difficile colitis. Clin Infect Dis. 2006 Aug 15; 43(4):421-7.
    View in: PubMed
    Score: 0.110
  22. Successful medical management of recurrent emphysematous pyelonephritis. Urology. 2006 Mar; 67(3):623.e11-3.
    View in: PubMed
    Score: 0.107
  23. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis. 2005 Jun 01; 40(11):1586-90.
    View in: PubMed
    Score: 0.101
  24. Sinusitis. N Engl J Med. 2005 Jan 13; 352(2):203-4; author reply 203-4.
    View in: PubMed
    Score: 0.099
  25. Doxycycline to Treat Community-Acquired Pneumonia. Clin Infect Dis. 2023 02 18; 76(4):692-693.
    View in: PubMed
    Score: 0.087
  26. Emergence of macrolide resistance during treatment of pneumococcal pneumonia. N Engl J Med. 2002 Feb 21; 346(8):630-1.
    View in: PubMed
    Score: 0.081
  27. A fresh look at the definition of susceptibility of Streptococcus pneumoniae to beta-lactam antibiotics. Arch Intern Med. 2001 Nov 26; 161(21):2538-44.
    View in: PubMed
    Score: 0.080
  28. Evaluation of a Paradigm Shift From Intravenous Antibiotics to Oral Step-Down Therapy for the Treatment of Infective Endocarditis: A Narrative Review. JAMA Intern Med. 2020 05 01; 180(5):769-777.
    View in: PubMed
    Score: 0.072
  29. Procalcitonin to Distinguish Viral From Bacterial Pneumonia: A Systematic Review and Meta-analysis. Clin Infect Dis. 2020 01 16; 70(3):538-542.
    View in: PubMed
    Score: 0.070
  30. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019 10 01; 200(7):e45-e67.
    View in: PubMed
    Score: 0.069
  31. Partial Oral Therapy for Osteomyelitis and Endocarditis. N Engl J Med. 2019 09 19; 381(12):1182.
    View in: PubMed
    Score: 0.069
  32. Diagnosis and management of pulmonary infection due to Rhodococcus equi. Clin Microbiol Infect. 2019 Mar; 25(3):310-315.
    View in: PubMed
    Score: 0.062
  33. Low procalcitonin, community acquired pneumonia, and antibiotic therapy. Lancet Infect Dis. 2018 05; 18(5):496-497.
    View in: PubMed
    Score: 0.062
  34. Evolving Understanding of the Causes of Pneumonia in Adults, With Special Attention to the Role of Pneumococcus. Clin Infect Dis. 2017 Oct 30; 65(10):1736-1744.
    View in: PubMed
    Score: 0.060
  35. Sensitivity, Specificity, and Positivity Predictors of the Pneumococcal Urinary Antigen Test in Community-Acquired Pneumonia. Ann Am Thorac Soc. 2015 Oct; 12(10):1482-9.
    View in: PubMed
    Score: 0.052
  36. Antimicrobial activities of beta-lactam antibiotics and gentamicin against penicillin-susceptible and penicillin-resistant pneumococci. Antimicrob Agents Chemother. 1995 May; 39(5):1166-8.
    View in: PubMed
    Score: 0.051
  37. Aerococcal infection at three US Tertiary Care Hospitals. South Med J. 2014 Oct; 107(10):642-7.
    View in: PubMed
    Score: 0.049
  38. Photo quiz. To scan or not to scan? Clin Infect Dis. 2013 Apr; 56(7):1003, 1052-3.
    View in: PubMed
    Score: 0.044
  39. Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study. J Infect. 2013 Jul; 67(1):11-8.
    View in: PubMed
    Score: 0.044
  40. Immunomodulatory agents in the treatment of community-acquired pneumonia: a systematic review. J Infect. 2011 Sep; 63(3):187-99.
    View in: PubMed
    Score: 0.039
  41. Antibiotic-resistant pneumonia in a hemophiliac with AIDS. Hosp Pract (Off Ed). 1991 Jan 15; 26(1):81-2.
    View in: PubMed
    Score: 0.038
  42. Inappropriate treatment of catheter-associated asymptomatic bacteriuria in a tertiary care hospital. Clin Infect Dis. 2009 May 01; 48(9):1182-8.
    View in: PubMed
    Score: 0.033
  43. Antibiotic stewardship and Clostridium difficile-associated disease. Infect Control Hosp Epidemiol. 2008 Nov; 29(11):1096-7.
    View in: PubMed
    Score: 0.032
  44. Guideline tyranny: a response to the article by Baum and Kaltsas. Clin Infect Dis. 2008 Oct 15; 47(8):1117-8.
    View in: PubMed
    Score: 0.032
  45. The usefulness of sputum gram stain and culture. Arch Intern Med. 2005 Feb 28; 165(4):470-1.
    View in: PubMed
    Score: 0.025
  46. Evaluation of Sch 29482 in experimental syphilis and comparison with penicillin G benzathine in disseminated disease and localized infection. Antimicrob Agents Chemother. 1984 Sep; 26(3):401-4.
    View in: PubMed
    Score: 0.024
  47. Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia. Clin Infect Dis. 2004 Jul 15; 39(2):165-9.
    View in: PubMed
    Score: 0.024
  48. Response of HIV-infected patients with asymptomatic syphilis to intensive intramuscular therapy with ceftriaxone or procaine penicillin. Int J STD AIDS. 2004 May; 15(5):328-32.
    View in: PubMed
    Score: 0.024
  49. Clinical prediction of bacteremia and early antibiotics therapy in patients with solid tumors. Infect Control Hosp Epidemiol. 2022 09; 43(9):1112-1118.
    View in: PubMed
    Score: 0.019
  50. Antibiotic susceptibilities of genetically characterized Streptococcus milleri group strains. Antimicrob Agents Chemother. 2001 May; 45(5):1511-4.
    View in: PubMed
    Score: 0.019
  51. Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study. Medicine (Baltimore). 2000 Jul; 79(4):210-21.
    View in: PubMed
    Score: 0.018
  52. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med. 2000 May 22; 160(10):1399-408.
    View in: PubMed
    Score: 0.018
  53. Is the pneumococcus the one and only in acute otitis media? Pediatr Infect Dis J. 2000 May; 19(5):399-400.
    View in: PubMed
    Score: 0.018
  54. Bowel Perforation Resulting in Necrotizing Soft-Tissue Infection of the Abdomen, Flank, and Lower Extremities. Surg Infect (Larchmt). 2018 Jul; 19(5):467-472.
    View in: PubMed
    Score: 0.016
  55. In vitro antimicrobial effect against Streptococcus pneumoniae of adding rifampin to penicillin, ceftriaxone, or 1-ofloxacin. Antimicrob Agents Chemother. 1995 Dec; 39(12):2798-800.
    View in: PubMed
    Score: 0.013
  56. Nasal methicillin-resistant Staphylococcus aureus polymerase chain reaction: a potential use in guiding antibiotic therapy for pneumonia. Perm J. 2015; 19(1):34-6.
    View in: PubMed
    Score: 0.012
  57. Interaction between acetohydroxamic acid and 12 antibiotics against 14 gram-negative pathogenic bacteria. Antimicrob Agents Chemother. 1974 Feb; 5(2):106-10.
    View in: PubMed
    Score: 0.012
  58. In vitro activities of streptomycin and 11 oral antimicrobial agents against clinical isolates of Klebsiella rhinoscleromatis. Antimicrob Agents Chemother. 1992 Aug; 36(8):1785-7.
    View in: PubMed
    Score: 0.010
  59. Pneumococcal pyomyositis: report of 2 cases and review of the literature. Clin Infect Dis. 2012 Aug; 55(3):e12-7.
    View in: PubMed
    Score: 0.010
  60. Elution of vancomycin, daptomycin, and amikacin from acrylic bone cement. Clin Orthop Relat Res. 1991 Mar; (264):302-8.
    View in: PubMed
    Score: 0.009
  61. Antibiotic-induced suprainfection. J Infect Dis. 1969 Jun; 119(6):662-5.
    View in: PubMed
    Score: 0.008
  62. Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis. Clin Infect Dis. 2009 Mar 01; 48(5):598-605.
    View in: PubMed
    Score: 0.008
  63. The gram-positive cocci: III. Resistance to antibiotics. Hosp Pract (Off Ed). 1988 May 15; 23(5):105-7, 111-2, 117-8 passim.
    View in: PubMed
    Score: 0.008
  64. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007 Mar 01; 44 Suppl 2:S27-72.
    View in: PubMed
    Score: 0.007
  65. In honor of Dr. Sarah Branham, a star is born. The realization of Branhamella catarrhalis as a respiratory pathogen. Chest. 1986 Sep; 90(3):447-50.
    View in: PubMed
    Score: 0.007
  66. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis. 2003 Dec 01; 37(11):1405-33.
    View in: PubMed
    Score: 0.006
  67. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore). 2003 Sep; 82(5):333-9.
    View in: PubMed
    Score: 0.006
  68. Fever and anemia of unknown origin. Hosp Pract (Off Ed). 1982 Jul; 17(7):134-5, 139.
    View in: PubMed
    Score: 0.005
  69. Critical importance of early diagnosis and treatment of intra-abdominal infection. Arch Surg. 1982 Mar; 117(3):328-33.
    View in: PubMed
    Score: 0.005
  70. Clavulanic acid and penicillin treatment of Staphylococcus aureus renal infection in mice. Antimicrob Agents Chemother. 1979 Dec; 16(6):798-800.
    View in: PubMed
    Score: 0.004
  71. Osteomyelitis: recent clinical and laboratory aspects. Orthop Clin North Am. 1979 Apr; 10(2):347-59.
    View in: PubMed
    Score: 0.004
  72. Disk diffusion susceptibility testing of Nocardia species. J Infect Dis. 1977 Apr; 135(4):568-76.
    View in: PubMed
    Score: 0.004
  73. Generation of formaldehyde from methenamine: effect of pH and concentration, and antibacterial effect. Antimicrob Agents Chemother. 1974 Dec; 6(6):708-11.
    View in: PubMed
    Score: 0.003
  74. Permanent carriers of nontyphosa salmonellae. Arch Intern Med. 1973 Dec; 132(6):869-72.
    View in: PubMed
    Score: 0.003
  75. A brief history of the pneumococcus in biomedical research: a panoply of scientific discovery. Clin Infect Dis. 1993 Nov; 17(5):913-24.
    View in: PubMed
    Score: 0.003
  76. Osteomyelitis beneath pressure sores. Arch Intern Med. 1983 Apr; 143(4):683-8.
    View in: PubMed
    Score: 0.001
  77. Articular and skeletal infections caused by Pasteurella multocida. South Med J. 1980 Oct; 73(10):1349-52.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.